title: Clinical impact and cost of laboratory monitoring need review even in resource-rich setting.
authors.forename: Shilpa
authors.initials: S
authors.lastname: Sayana
authors.forename: Marjan
authors.initials: M
authors.lastname: Javanbakht
authors.forename: Michael
authors.initials: M
authors.lastname: Weinstein
authors.forename: Homayoon
authors.initials: H
authors.lastname: Khanlou
mesh_terms: D000328:Adult; D019380:Anti-HIV Agents / Q000008:administration & dosage*; D023241:Antiretroviral Therapy, Highly Active / Q000379:methods*; D018791:CD4 Lymphocyte Count; D019411:Clinical Laboratory Techniques / Q000191:economics* / Q000379:methods*; D015331:Cohort Studies; D016903:Drug Monitoring / Q000191:economics* / Q000379:methods*; D005260:Female; D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D012367:RNA, Viral / Q000097:blood; D012189:Retrospective Studies; D016896:Treatment Outcome; D019562:Viral Load
chemical_list: D019380:Anti-HIV Agents; D012367:RNA, Viral